000			02336 a2200661 4500
005			20250517173646.0
264		0	_c20180523
008			201805s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdx274 _2doi
040			_aNLM _beng _cNLM
100	1		_aLe Bourgeois, A
245	0	0	_aReduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2017
300			_a2191-2198 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBusulfan _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation Conditioning
650	0	4	_aVidarabine _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aLabopin, M
700	1		_aBlaise, D
700	1		_aCeballos, P
700	1		_aVigouroux, S
700	1		_aPeffault de Latour, R
700	1		_aMarçais, A
700	1		_aBulabois, C E
700	1		_aBay, J O
700	1		_aChantepie, S
700	1		_aDeconinck, E
700	1		_aDaguindau, E
700	1		_aContentin, N
700	1		_aYakoub-Agha, I
700	1		_aCornillon, J
700	1		_aMercier, M
700	1		_aTurlure, P
700	1		_aCharbonnier, A
700	1		_aRorhlich, P S
700	1		_aN'Guyen, S
700	1		_aMaillard, N
700	1		_aMarchand, T
700	1		_aMohty, M
700	1		_aChevallier, P
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 9 _gp. 2191-2198
856	4	0	_uhttps://doi.org/10.1093/annonc/mdx274 _zAvailable from publisher's website
999			_c27565820 _d27565820